Belgian Biotech Stock News

What the CEO change and fresh earnings tell you about D'Ieteren Group D'Ieteren Group (ENXTBR:DIE) has just paired a leadership handover with fresh half year numbers, giving investors new information on both direction and current performance. The group reported €3,930.6 million in sales for the six months to 30 June 2026 compared with €4,052 million a year earlier. Over the same period, net income came in at €256.9 million versus €243.8 million previously. Basic earnings per share from...

As the new EU–Philippines free trade deal promises smoother customs, clearer rules and fresh routes for export-oriented manufacturing and electronics firms, some stocks in the EU–Philippines trade corridor suddenly look far more interesting. Tariffs and red tape shape profit pools, so shifts in trade policy can matter as much as quarterly earnings. This article spotlights 3 stocks exposed to the news that could sit on the right side of this agreement. The three stocks highlighted next are...

How the upcoming earnings date puts Viohalco on investors’ radar Viohalco (ENXTBR:VIO) is set to publish its first half 2026 final results on 17 September 2026. This scheduled update gives investors fresh numbers to reassess the stock. The Brussels headquartered industrial group operates across aluminium, copper, cables, steel, steel pipes, real estate and other activities. The announcement will therefore cover a broad mix of end markets and revenue sources. Over the past year, momentum in...

UCB reported that the FDA previously granted Breakthrough Therapy Designation to CIMZIA for preventing placenta-mediated adverse pregnancy outcomes in high-risk pregnant women with antiphospholipid syndrome who are positive for lupus anticoagulant, supported by preliminary IMPACT study data. The designation highlights a rare, underserved indication where CIMZIA could potentially extend its immunology footprint into high-complexity obstetric care, which aligns closely with UCB’s focus on...

Elia Group (ENXTBR:ELI) drew fresh attention after its recent share move, with the price closing at €120.70. Investors are now reassessing the regulated grid operator’s value using its latest reported financial metrics. Recent trading tells a mixed story for Elia Group. The share price return has dipped over the past month and quarter, yet the year to date gain of 7.58% and 1 year total shareholder return of 27.47% suggest longer term momentum has held up better than the latest pullback...

DEME Group (ENXTBR:DEME) has drawn investor attention after recent share performance, with the stock last closing at €182.40. That move sits alongside year-to-date and 1-year total returns in the mid to high double digits. For context, DEME Group’s 1 month share price return of 8.2% sits on top of a 27.7% year to date move, while the 1 year total shareholder return of 45.8% and 3 year total shareholder return of 85.9% suggest momentum has been building rather than fading. Compare DEME Group’s...

Cenergy Holdings entered this earnings day with a stock that had slipped over the past week, month, and quarter, while maintaining a P/E of 19.5x that still sat below European electrical peers. The company then delivered what often drives sentiment in heavy infrastructure: a sharp step up in profitability, with net profit margin at 10.8% over the last year compared with 8.9% previously. Investors are now weighing whether that margin story and upgraded adjusted EBITDA guidance justify a share...

Warehouses De Pauw (ENXTBR:WDP) is back in focus after recent trading left its month return roughly flat and its past 3 months performance down about 4%, inviting a closer look at today’s €20.96 share price. Over the past year, Warehouses De Pauw has seen its 1 year total shareholder return reach 3.76%, even as the year to date share price return is down 4.9% and the 5 year total shareholder return has declined 36.26%. This points to fading longer term momentum despite some recent...

The Europe molecular sieves market is projected to grow, supported by tighter EU environmental rules and rising medical oxygen demand. This trend is putting Solvay (ENXTBR:SOLB) and its basic chemicals portfolio on many investors’ radar. Solvay’s recent share price has drifted lower, with the 90 day share price return down 6.83% and the year to date share price return down 5.27%. However, the 3 year total shareholder return of 41.22% hints that long term holders have still seen solid value...

D'Ieteren Group reported half year 2026 sales of €3,930.6 million and net income of €256.9 million, alongside higher basic and diluted earnings per share from continuing operations compared with the prior year period. The company also confirmed a CEO transition, with Eric Machiels, who has investment and operational experience at OMERS and Infinis Energy, set to succeed Francis Deprez from December. This development may reshape how investors think about capital allocation and execution...

Lotus Bakeries (ENXTBR:LOTB) has drawn fresh attention after its recent share price performance, with the stock up about 51% over the past year and roughly 66% over three years. Recent trading has been choppy, with a 7-day share price return slightly in the red and a softer 30-day move. Even so, Lotus Bakeries still carries strong momentum given its year-to-date share price return near 48% and a 5-year total shareholder return above 100%, which points to sustained investor optimism about its...

Aedifica/SA: earnings jump, dividend guidance and investor focus Aedifica/SA (ENXTBR:AED) just paired a sharp move in half year 2026 results with fresh dividend guidance and an upcoming appearance at the EPRA Milan Conference on 8 September 2026. The healthcare focused real estate group reported half year sales of €292.31 million and net income of €509.57 million, both well above the prior year period, while basic earnings per share reached €7.28 from continuing operations. Management also...

Viohalco stock has turned a long holding period into a strong outcome over the past five years, yet the broader valuation checks now lean toward the shares looking expensive rather than like an obvious bargain. Over five years, Viohalco has returned about 276%, which puts the recent slide into perspective and raises the question of how much of the story is already in the price. Future earnings and cash generation from its metals and industrial operations can support the current market value,...

UCB (ENXTBR:UCB) just received Breakthrough Therapy Designation from the FDA for CIMZIA in antiphospholipid syndrome related pregnancy complications. Investors now have a fresh R&D catalyst to weigh against recent share performance. In the short term, UCB’s 1-day share price return of 1.93% and latest close at €205.6 only partly offset a 90-day share price decline of 25.21%. However, the 3-year total shareholder return of 148.78% indicates that the longer-term momentum has been much stronger...

Earnings jump puts Gimv in focus Gimv (ENXTBR:GIMB) has moved into the spotlight after reporting half year net income of €148.34 million and basic earnings per share of €4.03, both higher than the prior period. The latest half year figures arrive as Gimv's share price edges higher, with a 1 day share price return of 2.25% and a 1 month share price return of 3.53%, while the 3 year total shareholder return of 26.11% points to momentum that has built gradually over time rather than in a single...

Eurozone power and utility stocks are suddenly in the spotlight as the ECB pushes rates to 2.5% and fresh conflict risk keeps oil above $105 and gas prices elevated. Higher funding costs and stubborn inflation are reshaping how investors think about regulated grids and power producers. This article unpacks that story and walks through 3 European regulated utilities and power stocks that appear especially exposed to these shocks. The stocks highlighted below are just a starting sample, and the...

Investors came in treating D'Ieteren Group as a high‑multiple compounder with something to prove after a choppy few weeks for the share price. The stock is down about 4% over 7 days and 6% over a month to €167.40. The headline from these half year numbers is simple: profit did the heavy lifting, not sales. Net income for H1 landed at €256.9m on revenue of €3,930.6m, keeping the earnings story alive even as top line momentum softened. For a stock already on a premium P/E, that profit...

Onward Medical walked into this earnings day with a warm tailwind. The stock had gained about 20% over the past month and more than 15% across the last week, so expectations were already elevated. The headline from the release is simple and emotional. The company is still burning cash hard, with a net loss of €24.7m in the first half of 2026, while the share price reflects a rich story stock on a steep price to sales multiple of 23.1x. That clash between heavy losses and lofty valuation is...

As European markets navigate mixed economic signals and geopolitical developments, the pan-European STOXX Europe 600 Index remains relatively stable, reflecting a cautious investor sentiment. Against this backdrop, dividend stocks can offer a potential source of steady income for investors seeking stability amid market fluctuations.

Shareholders in ageas SA/NV ( EBR:AGS ) may be thrilled to learn that the analysts have just delivered a major upgrade...

Care Property Invest stock has barely budged over the past month, yet the latest earnings forced investors to confront a gap between income headlines and cash reality. Reported earnings over the last year look strong and help support an 8.05% dividend yield, while the stock trades on a P/E of 8.5x against higher peer and sector averages. The catch is that a large one off gain lifted those earnings. Today’s muted reaction looks more like a market waiting for clarity on sustainable cash flows...

Aedifica came into these results with a tired share price. The stock is down about 3% over the past month and only slightly higher over three months, which signals low conviction despite a headline P/E of 8.9x that screens cheap against healthcare real estate peers. The earnings story that hit the tape focuses on earnings power rather than accounting noise. Investors are weighing a half year in which European Public Real Estate Association earnings per share reached €2.71 and full-year...

Kinepolis Group (ENXTBR:KIN) drew investor attention after reporting half year 2026 earnings on 20 August. Sales were €341.84 million and net income was €25.27 million, both above the prior year period. Kinepolis Group shares have moved higher around the earnings release, with a 30-day share price return of 17.41% and a 90-day share price return of 59.83% to €47.55, while the 1-year total shareholder return of 46.55% points to building momentum. Scan other cinema and leisure stocks showing...

As European markets navigate mixed economic data and geopolitical developments, the pan-European STOXX Europe 600 Index remains relatively stable, reflecting cautious optimism among investors. In this environment, dividend stocks may offer a compelling opportunity for those seeking income stability amidst market fluctuations.